Loading financial data...

Greater Cannabis Company, Inc. (GCAN) Financial Statements | Global Financial Data

Greater Cannabis Company, Inc.

GCANSEC EDGAR

Pharmaceutical Preparations(FL)CIK: 1695473

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue from Contract with Customer, Excluding Assessed Tax	—	—	$12.6K	$48.0K	$7.1K
Cost of Goods and Services Sold	—	—	$12.7K	$48.1K	$3.1K
Gross Profit	—	—	-$25.00	-$46.00	$4.0K
Operating Expenses	$175.4K	$177.0K	$343.1K	$294.4K	$529.3K
Operating Income (Loss)	-$175.4K	-$177.0K	-$343.1K	-$294.5K	-$525.3K
Interest Expense	—	—	—	—	—
Nonoperating Income (Expense)	-$13.0K	-$183.2K	-$259.1K	-$656.7K	-$1.1M

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Assets	$172.3K	$280.4K	$392.9K	$180.1K	$52.7K
Assets, Current	$166.9K	$270.0K	$377.5K	$159.7K	$52.7K
Cash and Cash Equivalents, at Carrying Value	—	$270.0K	$377.5K	$113.0K	$24.7K
Liabilities	$833.5K	$825.3K	$862.0K	$459.9K	$1.6M
Liabilities, Current	$898.1K	$833.5K	$825.3K	$862.0K	$459.9K
Accounts Payable, Current	$6.1K	$16.3K	$11.7K	$6.7K	$17.5K
Stockholders' Equity Attributable to Parent	-$544.8K	-$469.1K	-$279.8K	-$1.5M

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Net Cash Provided by (Used in) Operating Activities	-$103.2K	-$107.5K	-$235.4K	-$289.6K	-$285.2K
Net Cash Provided by (Used in) Investing Activities	—	—	—	-$61.8K	-$61.8K
Net Cash Provided by (Used in) Financing Activities	—	—	$500.0K	$439.7K	$250.0K

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)